AIP
BNGO icon

Ahrens Investment Partners’s Bionano Genomics BNGO Stock Holding History

Ahrens Investment Partners’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1.39K Buy
+2
New +$1.78K ﹤0.01% 925
2022
Q3 		– Sell
-2
Closed -$2K – 256
2022
Q2 		$2K Hold
2
– – ﹤0.01% 858
2022
Q1 		$3K Hold
2
– – ﹤0.01% 900
2021
Q4 		$4K Buy
+2
New +$5.35K ﹤0.01% 896

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ahrens Investment Partners's BNGO Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Bionano Genomics (BNGO) in Q1 2023: 2 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #925 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in BNGO as recently as Q2 2022.

Ahrens Investment Partners first reported a position in BNGO in Q4 2021 and has held it in 4 quarters since. The position peaked at $4K in Q4 2021. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Ahrens Investment Partners held 2 shares of Bionano Genomics worth $1.39K as of Q1 2023.
  • Bionano Genomics was a new Ahrens Investment Partners position in Q1 2023.
  • Bionano Genomics made up ﹤0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #925 holding.
  • Ahrens Investment Partners first reported a position in Bionano Genomics in Q4 2021 and has held it in 4 quarters since.
  • Ahrens Investment Partners's Bionano Genomics position peaked at $4K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.